A Study on Suicidality, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or Lisdexamfetamine
Condition: Attention Deficit Disorder With Hyperactivity Interventions: Drug: Methylphenidate; Drug: Lisdexamfetamine; Drug: Atomoxetine; Drug: Amphetamine; Drug: Dextroamphetamine Sponsor: Janssen Research & Development, LLC Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adderall | Amphetamine | Concerta | Hyperactivity | Methylphenidate | Research | Ritalin | Strattera | Study | Substance Abuse | Substance Abuse Disorders | Vyvanse